Navigation Links
Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Date:3/13/2013

JUPITER, Fla., March 13, 2013 /PRNewswire-USNewswire/ -- The Scripps Research Institute (TSRI) and the Takeda Pharmaceutical Company have announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseases.

The new agreement extends an initial collaboration launched in 2010 between scientists on the Florida campus of TSRI and Envoy Therapeutics that led to several breakthroughs in identifying potential new compounds for neurological and psychiatric diseases. Envoy was acquired by Takeda Pharmaceuticals last November.

"We're pleased to expand our partnership with Takeda-Envoy and to push promising drug discovery efforts forward," said Scott Forrest , TSRI's vice president for business development. "The high-throughput screening capability at Scripps Florida campus is in increasing demand—both from other research institutes and from industry."

Scripps Florida's state-of-the art high-throughput screening facility is part of its larger translational research infrastructure. The facility has expertise in transforming slow, labor-intensive biological and biochemical bench-top experiments into high-throughput screening experiments ("screens"). Fully automated robotic screening platforms then rapidly test more than 650,000 drug-like compounds for pharmacologic activity. After completion of the screens, the facility uses other cutting-edge technologies to support the development of clinically relevant compounds.

Stephen Hitchcock , senior vice president of drug discovery at Envoy said, "We originally came to Jupiter because of Scripps Florida and are thrilled that the potential of our original collaboration has been realized. Now we're moving into new therapeutic areas with different biological targets. The first step is to f
'/>"/>

SOURCE The Scripps Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Researchers at Scripps to Study Possible New Treatment for Parkinsons Disease
2. Scripps Research Institutes Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research
3. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
4. Innovative Research Collaboration to Advance Next-Generation Methods in Peptide Discovery for Cosmeceuticals
5. Bio-Rad Receives the 2012 Frost & Sullivan North America Laboratory Researchers Choice Award for Future Market Leader
6. Biologics Research Promises to Bolster Future of Medicine
7. Life Science Research Tools Market Size, Growth and Trends 2006-2016
8. Pancreatic Cancer Action Network Opposes Sequestration Cuts To National Institutes Of Health & Cancer Research Grants
9. New Research on the Transcatheter Aortic Valve Market Now Available
10. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
11. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... , Sept. 20, 2014 /CNW/ - The issue: Mylan Pharmaceuticals ... all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due ... of the pump component. A missing "dip ... nitroglycerin to the patient. This defect may lead patients to ... are unable to access it. Not receiving nitroglycerin could place ...
(Date:9/19/2014)... Sept. 19, 2014 Medical science liaisons ... with key opinion leaders (KOLs) who can provide ... the critical nature of the MSL function, the ... altering the landscape for creating and maintaining KOL ... research, the oversight responsibility for the MSL function ...
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... May 20 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: ... treatment in the Phase 1 clinical study of ... of,phenylketonuria (PKU). The study is expected to conclude ... are dedicated to serving the PKU community and ...
... Claims Suggests a Benefit,of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among ... ... Data from a new analysis of the,Active Ulcerative Colitis Trials (ACT ... percent of patients with moderately to severely active,ulcerative colitis (UC) receiving ...
Cached Medicine Technology:BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU 2BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8
(Date:9/20/2014)... Increases in household, construction and ... treatment volumes. However, government regulations and higher landfill ... According to IBISWorld industry analyst Alen Allday, “over ... at reducing the volume of waste generated, and ... Still, a large proportion of waste generated by ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Ticket Down ... concert tickets . This popular ticket exchange is offering ... , The 2015 schedule of tours is beginning to ... already announced their plans to hit the road, including 21-year-old ... Fla., announced the “Honeymoon Tour,” which will take her to ...
(Date:9/20/2014)... 20, 2014 Ticket Down is ... tickets. This popular ticket exchange is offering their customer ... is nearing that next step in the entertainment business. The ... in the music and entertainment business, but is closing in ... straight No. 1 album, will hit the road next year ...
(Date:9/20/2014)... On Monday, September 22, Loma Linda University ... grant from Hyundai Hope on Wheels at a check ... on 11234 Anderson St., in Loma Linda. The grant ... Professor at Loma Linda University and Director of Translational ... , Loma Linda University Medical Center is ...
(Date:9/20/2014)... York (PRWEB) September 20, 2014 ... to grow in federal court, Bernstein Liebhard LLP ... Drug Administration (FDA) have voted overwhelmingly to recommend ... in men be subjected to further study in ... a report published on September 18th by Bloomberg.com, ...
Breaking Medicine News(10 mins):Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3
... 1 As the economic crisis deepens, SilverCensus.com ... a national web site for caregivers, senior citizens, ... urging American Veterans to investigate and take advantage ... called "Aid and Attendance." ...
... Mass., April 1, EnVivo Pharmaceuticals today ... Corporation (MTPC) for the development and commercialization ... Japan and several other Asian countries. EVP-6124 ... agonist currently in development for cognition enhancement ...
... Laboratories, Inc. Immunotech Laboratories announces successful Participation in ... its abstract " Irreversible Pepsin Fraction (IPF) displays ... in vitro investigation of activity on human lymphocytes." ... Conference on Clinical and Social Research on AIDS ...
... worse cholesterol, blood vessel health than with South Beach, Ornish ... the "maintenance" phase that occurs after initial weight loss, the ... on the heart than the high-fat, low-carbohydrate Atkins regimen, a ... diets to see which might be better at achieving weight ...
... April 1 Harvest Technologies Corp. ... study report was completed for the first thirty (30) ... non-reconstructable critical limb ischemia due to advanced thromboangitis obliterans, ... is being conducted at Sri Ramachandra University in Chennai ...
... VC Business Practices to Funding ResearchTUCSON, Ariz., April 1 ... launch of a new initiative, MDA Venture Philanthropy (MVP), ... A 501(c)(3) nonprofit organization, MVP will break with traditional ... of venture capital firms to fast track the development ...
Cached Medicine News:Health News:Little-Known VA Care Entitlement for Veterans Highlighted by SilverCensus.com 2Health News:Little-Known VA Care Entitlement for Veterans Highlighted by SilverCensus.com 3Health News:EnVivo and Mitsubishi Tanabe Enter License Agreement on EVP-6124 in Japan, Korea, Taiwan and Other Asian Countries 2Health News:EnVivo and Mitsubishi Tanabe Enter License Agreement on EVP-6124 in Japan, Korea, Taiwan and Other Asian Countries 3Health News:Beating a Global Killer: HIV/AIDS 2Health News:Beating a Global Killer: HIV/AIDS 3Health News:Beating a Global Killer: HIV/AIDS 4Health News:Atkins Diet Tougher on Heart After Weight Loss 2Health News:Atkins Diet Tougher on Heart After Weight Loss 3Health News:Harvest Technologies Announces Interim Study Results From Critical Limb Ischemia Trial in Chennai India 2Health News:Harvest Technologies Announces Interim Study Results From Critical Limb Ischemia Trial in Chennai India 3Health News:Muscular Dystrophy Association Launches New Venture Philanthropy 2Health News:Muscular Dystrophy Association Launches New Venture Philanthropy 3
Delicate membrane hook/pick with hook on side of instrument for engaging membranes. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare. Right....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
Teardrop shape tip with post. Round knurled handle with dull finish....
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat...
Medicine Products: